Join

Compare · IBBJ vs JHB

IBBJ vs JHB

Side-by-side comparison of Defiance Nasdaq Junior Biotechnology ETF (IBBJ) and Nuveen High Income November 2021 Target Term Fund (JHB): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both IBBJ and JHB operate in n/a (n/a), so they compete in similar markets.
  • JHB carries a market cap of $525.4M.
MetricIBBJJHB
Company
Defiance Nasdaq Junior Biotechnology ETF
Nuveen High Income November 2021 Target Term Fund
Price
$29.45-10.89%
$9.39+0.00%
Market cap
-
$525.4M
1M return
-
-
1Y return
-
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NYSE
IPO
n/a
2016
News (4w)
0
0
Recent ratings
0
0
IBBJ

Defiance Nasdaq Junior Biotechnology ETF

The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.